Comparative law and regulation of therapeutic use of cord stem cellsA conversion of biological waste to a gift for life

  1. Manca, R. 1
  2. Pica, A. 1
  3. Bombillar-Sáenz, F. 1
  1. 1 University of Naples Federico II
    info

    University of Naples Federico II

    Nápoles, Italia

    ROR https://ror.org/05290cv24

Revista:
DS : Derecho y salud

ISSN: 1133-7400

Año de publicación: 2019

Título del ejemplar: Extraordinario XXVIII Congreso 2019: Ética, innovación y transparencia en salud

Volumen: 29

Número: 1

Páginas: 278-286

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Otras publicaciones en: DS : Derecho y salud

Resumen

Currently cord blood is considered an innovative and particularly useful source of stem cells. They can be readily stored in biobanks. The success of the early cord blood transplantations stimulated the establishment of cord blood banks and of legislation to regulate collection, processing, and storage of donated cord blood. In Europe the specific technical quality and safety requirements for samples of cord blood are regulated by three directives (2004/23/EC, 2006/17/EC, 2006/86/EC), transposed by members of European Union into national legislation and integrated with specific national laws. Two main cord blood banking options are available: non-profit public and commercial private banks. The latter are disallowed in most European Community member because of their speculative and marketplace dealings.

Fuente de los datos: Dialnet